Skip to main content

Table 9 Stability study results at different conditions n = 3

From: Analytical method for simultaneous quantification of levodopa and carbidopa in the injectable oleogel formulation by HPLC

Drugs name

Testing conditions

R % ± SD

Day 1

Day 3

Day 7

Day 14

LD

Mobile phase at RT

100.06 ± 0.01

100.33 ± 0.04

100.04 ± 0.01

100.09 ± 0.02

Mobile phase at 4 °C

100.02 ± 0.01

100.19 ± 0.05

100.01 ± 0.04

100.26 ± 0.06

pH 7.4 at RT

99.71 ± 0.02

99.98 ± 0.00

99.82 ± 0.06

99.68 ± 0.02

pH 7.4 at 4 °C

99.72 ± 0.02

99.88 ± 0.03

99.84 ± 0.05

99.53 ± 0.03

CD

Mobile phase at RT

99.49 ± 0.01

99.18 ± 0.02

98.90 ± 0.04

97.29 ± 0.05

Mobile phase at 4 °C

99.76 ± 0.07

99.43 ± 0.09

99.76 ± 0.08

99.58 ± 0.23

pH 7.4 at RT

98.11 ± 0.15

98.33 ± 0.09

96.69 ± 0.03

94.64 ± 0.07

pH 7.4 at 4 °C

98.73 ± 0.05

98.47 ± 0.09

98.52 ± 0.12

98.41 ± 0.14